Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TriRx Huntsville Pharmaceutical Services is a contract development and manufacturing organization (CDMO) that provides specialized services for the pharmaceutical and life sciences industries. Located in Huntsville, Alabama, the facility focuses on the formulation, manufacturing, and packaging of oral solid, liquid, and semi-solid dosage forms. The site was formerly operated by Sanofi and iPharma before being acquired by TriRx, bringing a legacy of high-quality standards and large-scale production capabilities. TriRx Huntsville offers end-to-end solutions from clinical-scale development to full commercialization, supporting a wide range of therapeutic products. The company is recognized for its expertise in complex non-sterile topicals and efficient supply chain management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trirx Huntsville Pharmaceutical Services.